Collegium Pharmaceutical Inc (COLL)
30.40
+0.40
(+1.33%)
USD |
NASDAQ |
Nov 21, 16:00
30.40
0.00 (0.00%)
After-Hours: 16:16
Collegium Pharmaceutical Price to Book Value: 4.185 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 4.130 |
| November 19, 2024 | 4.095 |
| November 18, 2024 | 4.022 |
| November 15, 2024 | 4.072 |
| November 14, 2024 | 4.167 |
| November 13, 2024 | 4.154 |
| November 12, 2024 | 4.324 |
| November 11, 2024 | 4.430 |
| November 08, 2024 | 4.427 |
| November 07, 2024 | 4.778 |
| November 06, 2024 | 4.749 |
| November 05, 2024 | 4.600 |
| November 04, 2024 | 4.504 |
| November 01, 2024 | 4.606 |
| October 31, 2024 | 4.700 |
| October 30, 2024 | 4.770 |
| October 29, 2024 | 4.848 |
| October 28, 2024 | 4.833 |
| October 25, 2024 | 4.774 |
| October 24, 2024 | 4.720 |
| October 23, 2024 | 4.937 |
| October 22, 2024 | 4.979 |
| October 21, 2024 | 5.016 |
| October 18, 2024 | 5.288 |
| October 17, 2024 | 5.356 |
| Date | Value |
|---|---|
| October 16, 2024 | 5.412 |
| October 15, 2024 | 5.301 |
| October 14, 2024 | 5.228 |
| October 11, 2024 | 5.189 |
| October 10, 2024 | 5.041 |
| October 09, 2024 | 5.167 |
| October 08, 2024 | 5.230 |
| October 07, 2024 | 5.475 |
| October 04, 2024 | 5.759 |
| October 03, 2024 | 5.488 |
| October 02, 2024 | 5.394 |
| October 01, 2024 | 5.462 |
| September 30, 2024 | 5.316 |
| September 27, 2024 | 5.691 |
| September 26, 2024 | 5.722 |
| September 25, 2024 | 5.563 |
| September 24, 2024 | 5.621 |
| September 23, 2024 | 5.683 |
| September 20, 2024 | 5.811 |
| September 19, 2024 | 5.790 |
| September 18, 2024 | 5.768 |
| September 17, 2024 | 5.560 |
| September 16, 2024 | 5.520 |
| September 13, 2024 | 5.578 |
| September 12, 2024 | 5.433 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.409
Minimum
Dec 01 2021
9.912
Maximum
Feb 07 2020
4.395
Average
4.245
Median
Oct 14 2020
Price to Book Value Benchmarks
| Pfizer Inc | 1.543 |
| Context Therapeutics Inc | 1.346 |
| NovaBay Pharmaceuticals Inc | 3.291 |
| Palatin Technologies Inc | -- |
| iBio Inc | 1.263 |
Price to Book Value Related Metrics
| PE Ratio | 13.05 |
| PS Ratio | 2.330 |
| PEG Ratio | 0.0090 |
| Price to Free Cash Flow | 7.255 |
| Price | 30.40 |
| Earnings Yield | 7.66% |
| Market Cap | 980.41M |
| PEGY Ratio | 0.0090 |
| Operating PE Ratio | 7.216 |
| Normalized PE Ratio | 12.10 |